EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer

Farah Benyettou, Mostafa Khair, Thirumurugan Prakasam iD, Sabu Varghese, Zineb Matouk, Maryam Alkaabi, Pilar Pena-Sánchez iD, Maylis Boitet, Rasha AbdulHalim, Sudhir Kumar Sharma, Rose Ghemrawi, Sneha Thomas und 5 weitere

ACS Applied Materials & Interfaces · 23.10.2024 · 16 (42) · 56676-56695

DOI: 10.1021/acsami.4c10812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 13.09.2024. Verfasst von Farah Benyettou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirates. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Peptides, Cyclic, Doxorubicin, Metal-Organic Frameworks. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ASPIRE, New York University Abu Dhabi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPeptides, CyclicDoxorubicinMetal-Organic FrameworksHumansFemaleAnimalsCell Line, TumorMiceAntineoplastic AgentsDrug LiberationDrug CarriersPrecision Medicine

Stichwörter der Autor:innen

covalent organic frameworks (COFs)integrin-targeting RGD peptidespH-responsive nanoparticlestargeted drug deliverytriple-negative breast cancer (TNBC)

Substanzen

cyclic arginine-glycine-aspartic acid peptidePeptides, CyclicDoxorubicinMetal-Organic FrameworksAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirates.
  • Core Technology Platforms, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates.
  • Technology Innovative Institute, P.O. Box 9639, Abu Dhabi 9639, United Arab Emirates.
  • Instituto de Ciencia de Materiales de Madrid-CSIC, C. Sor Juana Inés de La Cruz 3, Madrid 28049, Spain.
  • Engineering Division, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates.
  • College of Pharmacy, Al Ain University, P.O. Box 112612, Abu Dhabi 112612, United Arab Emirates.

ORCID-Profile: Thirumurugan Prakasam, Pilar Pena-Sánchez, Jamie Whelan, Ramesh Jagannathan, Felipe Gándara, Ali Trabolsi

Förderung

  • ASPIRE
  • New York University Abu Dhabi

Zitieren

APA

Benyettou, F., Khair, M., Prakasam, T., Varghese, S., Matouk, Z., Alkaabi, M., Pena-Sánchez, P., Boitet, M., AbdulHalim, R., Sharma, S. K., Ghemrawi, R., Thomas, S., Whelan, J., Pasricha, R., Jagannathan, R., Gándara, F., & Trabolsi, A. (2024). cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces, 16(42), 56676-56695. https://doi.org/10.1021/acsami.4c10812

Vancouver

Benyettou F, Khair M, Prakasam T, Varghese S, Matouk Z, Alkaabi M, et al. cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2024;16(42):56676-56695. doi:10.1021/acsami.4c10812

BibTeX
@article{Benyettou2024,
  author = {Benyettou, Farah and Khair, Mostafa and Prakasam, Thirumurugan and Varghese, Sabu and Matouk, Zineb and Alkaabi, Maryam and Pena-Sánchez, Pilar and Boitet, Maylis and AbdulHalim, Rasha and Sharma, Sudhir Kumar and Ghemrawi, Rose and Thomas, Sneha and Whelan, Jamie and Pasricha, Renu and Jagannathan, Ramesh and Gándara, Felipe and Trabolsi, Ali},
  title = {cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  volume = {16},
  number = {42},
  pages = {56676--56695},
  doi = {10.1021/acsami.4c10812}
}
Kostenlos starten →